Ledger.Open graph →
SEC Form D · filed January 20, 2017

Ovid Therapeutics Inc

Offering
$25.9M
Sold
$25.9M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
New York, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Jeremy M. Levin · New York, NYExec · DirectorMatthew J. During · New York, NYExec · DirectorAmit E. Rakhit · New York, NYExecBart M. Friedman · New York, NYDirectorYaron M. Werber · New York, NYExecDouglas E. Williams · Berkeley, CADirectorKaren E. Bernstein · New York, NYDirectorAmit E. Rakhit · New York, NYExecBart M. Friedman · New York, NYDirectorYaron M. Werber · New York, NYExecJeremy M. Levin · New York, NYExec · DirectorDouglas E. Williams · San Diego, CADirectorKaren E. Bernstein · New York, NYDirectorMatthew J. During · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗